Sixten Borg

1.7k citations

43 papers · 1.3k indexed · h-index 18

Impact in

Issues, ethics and legal aspects top 2%
Pulmonary and Respiratory Medicine top 5%
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Respiratory Support and Mechanisms
- Respiratory and Cough-Related Research

Papers in ⓘ

Economics and Econometrics 15
- Health Systems, Economic Evaluations, Quality of Life 14
Pulmonary and Respiratory Medicine 13
- Chronic Obstructive Pulmonary Disease (COPD) Research 10

Co-authors: Fredrik Andersson (7 shared papers)Bo Lundbäck (5 shared papers)Sven‐Arne Jansson (7 shared papers)Lene Riis (3 shared papers)Pia Munkholm (3 shared papers)Tine Jess (2 shared papers)Ida Vind (1 shared paper)Vibeke Binder (1 shared paper)
Journals: Value in Health (8 papers)BMJ Open (2 papers)Respiratory Medicine (2 papers)Acta Oncologica (2 papers)Acta Neurologica Scandinavica (2 papers)
Partner nations: Sweden United Kingdom United States

In The Last Decade

Sixten Borg

42 papers receiving 1.3k citations

Peers

Countries citing papers authored by Sixten Borg

Since Specialization

Citations

This map shows the geographic impact of Sixten Borg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sixten Borg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sixten Borg more than expected).

Fields of papers citing papers by Sixten Borg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sixten Borg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sixten Borg. The network helps show where Sixten Borg may publish in the future.

Co-authors

The 25 scholars most cited alongside Sixten Borg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sixten Borg Line = papers co-authored together Sixten Borg links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Changes in Clinical Characteristics, Course, and Prognosis of Inflammatory Bowel Disease during the Last 5 Decades: A Population-Based Study from Copenhagen, Denmark Inflammatory Bowel Diseases ·Tine Jess, Lene Riis, Ida Vind, Karen V. Winther, Sixten Borg, Vibeke Binder, Ebbe Langholz, Ole Stergaard Thomsen, Pia Munkholm	2006	291
2	The costs of exacerbations in chronic obstructive pulmonary disease (COPD) Respiratory Medicine ·Fredrik Andersson, Sixten Borg, Sven‐Arne Jansson, Ann-Christin Jonsson, Åsa Ericsson, C Prütz, Eva Rönmark, Bo Lundbäck	2002	250
3	Costs of COPD in Sweden According to Disease Severity CHEST Journal ·Sven‐Arne Jansson, Fredrik Andersson, Sixten Borg, Åsa Ericsson, Elsy Jönsson, Bo Lundbäck	2002	144
4	A Computer Simulation Model of the Natural History and Economic Impact of Chronic Obstructive Pulmonary Disease Value in Health ·Sixten Borg, Åsa Ericsson, Jadwiga A. Wedzicha, Amund Gulsvik, Bo Lundbäck, Gavin C. Donaldson, Sean D. Sullivan	2004	76
5	Costs and quality of life in multiple sclerosis patients with spasticity Acta Neurologica Scandinavica ·Johanna Svensson, Sixten Borg, Petra C Nilsson	2013	57
6	Obesity, Survival, and Hospital Costs—Findings from a Screening Project in Sweden Value in Health ·Sixten Borg, Ulf Persson, Knut Ödegaard, Göran Berglund, Jan-Åke Nilsson, Peter M. Nilsson	2005	49
7	Health-related quality of life and glycaemic control among adults with type 1 and type 2 diabetes – a nationwide cross-sectional study Health and Quality of Life Outcomes ·Maria Svedbo Engström, Janeth Leksell, Unn‐Britt Johansson, Sixten Borg, Bo Palaszewski, Stefan Franzén, Soffia Guðbjörnsdóttir, Katarina Eeg‐Olofsson	2019	43
8	Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease: Cross-Model Comparison of Hypothetical Treatment Scenarios Value in Health ·Martine Hoogendoorn, Talitha Feenstra, Yumi Asukai, Sixten Borg, Ryan N. Hansen, Sven‐Arne Jansson, Yevgeniy Samyshkin, Margarethe Wacker, Andrew Briggs, Adam Lloyd, Sean D. Sullivan, Maureen Rutten‐van Mölken	2014	37
9	Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources International Journal of COPD ·Martine Hoogendoorn, Talitha Feenstra, Melinde Boland, Andrew Briggs, Sixten Borg, Sven‐Arne Jansson, Nancy Risebrough, Julia F. Slejko, Maureen Rutten‐van Mölken	2017	33
10	Drug and treatment costs in Parkinson’s disease patients in Sweden Acta Neurologica Scandinavica ·Johan Lökk, Sixten Borg, Johanna Svensson, U. Persson, G Ljunggren	2011	32
11	The Impact of Exacerbations on the Asthmatic Patient's Preference Scores Journal of Asthma ·Fredrik Andersson, Sixten Borg, Elisabeth Ståhl	2003	30
12	A disease-specific questionnaire for measuring patient-reported outcomes and experiences in the Swedish National Diabetes Register: Development and evaluation of content validity, face validity, and test-retest reliability Patient Education and Counseling ·Maria Svedbo Engström, Janeth Leksell, Unn‐Britt Johansson, Katarina Eeg‐Olofsson, Sixten Borg, Bo Palaszewski, Soffia Guðbjörnsdóttir	2017	29
13	Budesonide/formoterol in a single inhaler (Symbicort) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months. PubMed ·L Rosenhall, Sixten Borg, Fredrik Andersson, Karin Ericsson	2003	26
14	Patient-reported outcome and experience measures for diabetes: development of scale models, differences between patient groups and relationships with cardiovascular and diabetes complication risk factors, in a combined registry and survey study in Sweden BMJ Open ·Sixten Borg, Katarina Eeg‐Olofsson, Bo Palaszewski, Maria Svedbo Engström, Ulf‐G. Gerdtham, Soffia Guðbjörnsdóttir	2019	23
15	Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden Journal of Medical Economics ·Thomas Hofmarcher, Sixten Borg	2015	21
16	The Swedish cost burden of overweight and obesity – evaluated with the PAR approach and a statistical modelling approach International Journal of Pediatric Obesity ·Knut Ödegaard, Sixten Borg, U. Martin Persson, Marianne Svensson	2008	20
17	BUDESONIDE/FORMOTEROL IN A SINGLE INHALER (SYMBICORT®) REDUCES HEALTHCARE COSTS COMPARED WITH SEPARATE INHALERS IN THE TREATMENT OF ASTHMA OVER 12 MONTHS International Journal of Clinical Practice ·L Rosenhall, Sixten Borg, Fredrik Andersson, Karin Ericsson	2003	19
18	Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort The European Journal of Health Economics ·Ulf‐G. Gerdtham, Lars Andersson, Åsa Ericsson, Sixten Borg, Sven‐Arne Jansson, Eva Rönmark, Bo Lundbäck	2008	17
19	Cost Differences for COPD With and Without Physician-Diagnosis COPD Journal of Chronic Obstructive Pulmonary Disease ·Sven‐Arne Jansson, Anne Lindberg, Åsa Ericsson, Sixten Borg, Eva Rönmark, Fredrik Andersson, Bo Lundbäck	2005	16
20	Patient-Reported Outcome Measures and Risk Factors in a Quality Registry: A Basis for More Patient-Centered Diabetes Care in Sweden International Journal of Environmental Research and Public Health ·Sixten Borg, Bo Palaszewski, Ulf‐G. Gerdtham, Ödegaard Fredrik, Pontus Roos, Soffia Guðbjörnsdóttir	2014	15

About Sixten Borg

Sixten Borg is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine, Physiology, Epidemiology and General Health Professions, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers), Asthma and respiratory diseases (8 papers), Chronic Disease Management Strategies (6 papers), Diabetes Management and Education (4 papers), Global Health Care Issues (4 papers), Diabetes Management and Research (3 papers) and Emergency and Acute Care Studies (3 papers). The work is most often cited by research in Issues, ethics and legal aspects (51 citations), Pulmonary and Respiratory Medicine (609 citations), Physiology (300 citations), Epidemiology (389 citations) and Genetics (295 citations). Sixten Borg has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Fredrik Andersson, Bo Lundbäck, Sven‐Arne Jansson, Lene Riis, Pia Munkholm, Tine Jess, Ida Vind, Vibeke Binder, Ebbe Langholz and Karen V. Winther. Their work appears in journals such as Value in Health, BMJ Open, Respiratory Medicine, Acta Oncologica and Acta Neurologica Scandinavica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact